In conclusion, these assays demonstrate that cellular seeding propensity differs between ex vivo tau polymorphs and highlight a key role for the PAM4 segment, particularly for AD-, CBD-, and PSP-derived tau aggregates. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.